![]() Alchemab Therapeutics Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies. | ![]() Genelux Genelux is a clinical-stage biopharmaceutical company developing an oncolytic virus-based technology platform. | Remedy Plan Remedy Plan Therapeutics is a biotechnology company developing drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis. | ABL Bio ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease. | ![]() Amunix Pharmaceuticals Amunix Pharmaceuticals is a biopharmaceutical company focused on immuno-oncology. | |
Founding Date | Founding Date 2019 | Founding Date 2001 | Founding Date 2011 | Founding Date 2016 | Founding Date 2006 |
Type | Type Private | Type Public | Type Private | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations London, GB HQ Babraham, GB | Locations Thousand Oaks, US HQ | Locations HQ | Locations HQ | Locations South San Francisco, US HQ |
Employees | Employees 512% decrease | Employees 157% increase | Employees 15 | Employees 615% increase | Employees 42 |
Funding | |||||
Latest funding round | Latest funding round $ 71.8m (about 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 65m (almost 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 71.8m | Total funding raised N/A | Total funding raised $ 10.1m | Total funding raised $ 90.8m | Total funding raised $ 190m |

Genelux is a clinical-stage biopharmaceutical company developing an oncolytic virus-based technology platform.
View companyRemedy Plan Therapeutics is a biotechnology company developing drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis.
View companyABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.
View company
Amunix Pharmaceuticals is a biopharmaceutical company focused on immuno-oncology.
View company